The structure of the rat liver aflatoxin dialdehyde reductase (AKR7A1) has been solved to 1.38-Å resolution. Although it shares a similar ␣/␤-barrel structure with other members of the aldo-keto reductase superfamily, AKR7A1 is the first dimeric member to be crystallized. The crystal structure also reveals details of the ternary complex as one subunit of the dimer contains NADP ؉ and the inhibitor citrate. Although the underlying catalytic mechanism appears similar to other aldoketo reductases, the substrate-binding pocket contains several charged amino acids (Arg-231 and Arg-327) that distinguish it from previously characterized aldo-keto reductases with respect to size and charge. These differences account for the substrate specificity for 4-carbon acid-aldehydes such as succinic semialdehyde and 2-carboxybenzaldehyde as well as for the idiosyncratic substrate aflatoxin B 1 dialdehyde of this subfamily of enzymes. Structural differences between the AKR7A1 ternary complex and apoenzyme reveal a significant hinged movement of the enzyme involving not only the loops of the structure but also parts of the ␣/␤-barrel most intimately involved in cofactor binding.
was purified as a cytosolic NAD(P)
ϩ -dependent reductase that is capable of reducing the dialdehyde phenolate metabolite of aflatoxin B 1 (1, 2) . The enzyme is of particular importance as it contributes toward resistance to the hepatocarcinogen aflatoxin B 1 in rats (2) and is inducible in rat liver through the inclusion of either natural or synthetic compounds in the diet (1, 3, 4) . Cloning and sequencing of the gene encoding this enzyme (3) identified it as belonging to the aldo-keto reductase (AKR) superfamily (5) and led to its assignation as the founder member of the AKR7 family (5) .
The aldo-keto reductases are a superfamily of enzymes that share a number of common structural features; in particular they have a (␤/␣) 8 -barrel structure that was first demonstrated for human aldose reductase (AKR1B1) (6, 7) . Subsequently the crystal structures of seven other members of the aldo-keto reductase family have been determined: porcine aldehyde reductase (AKR1A1) (8) , rat liver 3␣-hydroxysteroid dehydrogenase (AKR1C1) (9) , mouse FR1 protein (AKR1B8) (10), bacterial 2,5-diketo-D-gluconic acid reductase (AKR5C) (11) , Chinese hamster ovary reductase (AKR1B9) (12) , and recently yeast GCY1 (AKR3A1) (13) and human 3␣-hydroxysteroid dehydrogenase (AKR1C2) (14) . These enzymes show considerable diversity in terms of substrate specificity, catalyzing the reduction of a range of aliphatic and aromatic aldehydes and ketones, including sugars, steroids, and xenobiotics. Although structural information has revealed significant differences in the substrate-binding pocket, the relationships between structure and substrate specificity have not been fully determined. Site-directed mutagenesis of residues predicted to have important roles in binding of substrate and in catalysis has provided limited information on substrate specificity determinants. Recently a loop-swapping experiment, in which the three loop regions of 3␣-hydroxysteroid dehydrogenase (AKR1C1) were replaced by those from 20␣-hydroxysteroid dehydrogenase, created a chimeric enzyme that was able to reduce progestins instead of androgens (15) .
AKR7A1 is unusual among AKRs in that it is able to reduce aflatoxin B 1 dialdehyde (4) as shown in Scheme 1. However, it can also reduce a wide range of aldehydes and diketones and has particularly high affinity for succinic semialdehyde (SSA), 2-carboxy-benzaldehyde (2-CBA), and 9,10-phenanthrenequinone (16, 17) . Three other members of the AKR7 family have now been identified: these are human AKR7A2 (18) , human AKR7A3 (19) , and more recently rat AKR7A4 (17) . AKR7A2 and AKR7A3 are also able to reduce aflatoxin dialdehyde and have high affinity for SSA and 2-CBA (18, 19) . Reports also suggest that human AKR7A2 can function as a SSA reductase in brain and may play a role in the production of ␥-hydroxybutyrate (17, 20) . In addition, the AKR7A2 gene appears to be frequently deleted in human tumors, suggesting a role in detoxication of aldehyde carcinogens (21) . Because of the potential importance of the AKR7 family and their weak sequence identity to other members of the AKR superfamily, we have determined the structure of AKR7A1 with the objective of better understanding the substrate specificity of the enzyme and hence its biological role.
EXPERIMENTAL PROCEDURES
Crystallization-Recombinant AKR7A1 was overexpressed in and purified from Escherichia coli as described previously (3) . Purified enzyme was exhaustively dialyzed into 20 mM Tris/HCl, pH 7.5, 0.5 mM dithiothreitol and subsequently concentrated using Centricon-10 centrifugal concentrators (Amicon, Stonehouse, Gloucestershire, UK) to a concentration of 6 mg/ml. Dynamic light scattering experiments were * This work was supported by the "European Community-Access to Research Infrastructure Action of the Improving Human Potential Program" to the European Molecular Biology Laboratory Hamburg Outstation, Contract No. HPRI-1999-00017. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The 1 The abbreviations used are: AKR7A1, rat liver aflatoxin dialdehyde reductase; AKR, aldo-keto reductase; AKR6A2, rat voltage-dependent K ϩ channel ␤2-subunit; AKR1B1, human aldose reductase; 2-CBA, 2-carboxybenzaldehyde; SSA, succinic semialdehyde; r.m.s., root mean square.
performed on the enzyme (1 mg/ml concentration) using a DYNA-PRO 801 dynamic light scattering/molecular sizing instrument (Protein Solutions, Buckinghamshire, UK). These confirmed that the enzyme was monodispersed in solution with a hydrodynamic radius of 3.7 nm (estimated molecular mass of 68 kDa) consistent with the protein forming a dimer. Careful examination of the UV absorption of the sample at A 260 and A 280 confirmed that NADPH was present at a stoichiometry of one NADPH per polypeptide chain. The enzyme was then used in a number of in-house sparse matrix screens at 20°C using the sitting-drop vapordiffusion method. Crystals of AKR7A1 were grown by equilibrating a mixture of 1 l of protein solution and 1 l of precipitant solution (20% polyethylene glycol 8000, 0.2 M lithium sulfate, 0.1 M sodium citrate, pH 5.6) against 0.8 ml of the precipitant solution. Within a day large rhombohedral-shaped crystals were formed growing to maximum dimensions of 0.15 ϫ 0.15 ϫ 0.3 mm after 1 week.
Data Collection and Processing-A single crystal was loop-mounted in a drop of artificial mother liquor containing 25% (v/v) glycerol and flash frozen at 100 K using an Oxford Cryostream Cryosystem. X-ray diffraction data were collected on the European Molecular Biology Laboratory BW7B beamline at the DORIS storage ring (DESY, Hamburg, Germany) with a MAR 345-mm image plate system. The data were processed with DENZO and scaled using SCALEPACK (22) . One round of auto-indexing yielded a C-centered orthorhombic space group; however, from analysis of the R merge statistics it became clear that the true space group was monoclinic C2 with unit cell dimensions a ϭ 125.54 Å, b ϭ 64.68 Å, c ϭ 112.84 Å, and ␤ ϭ 91.0°. The diffraction was anisotropic with data effectively complete to 1.6 Å but only 46% complete between 1.43-and 1.38-Å resolution. Several different derivative data sets were collected, but attempts at multiple isomorphous replacement were unsuccessful due to significant anisomorphism between different native and derivative data sets.
Molecular Replacement-The choice of search model was not obvious as AKR7A1 is only distantly related to the other members of the aldo-keto reductase superfamily, sharing less than 20% amino acid sequence identity with most other members. However, the rat voltagedependent K ϩ channel ␤2-subunit (AKR6A2) (23) shares the highest sequence identity with AKR7A1 (26%), so the 2.1-Å structure of this protein (Protein Data Bank code 1EXB) (24) was used as the search model. Using the main chain atoms of this structure and data between 12.0-and 4.0-Å resolution a solution was obtained with AMoRe (25) (correlation coefficient 22.1 R-factor 71.1 after rigid body refinement). The solution was checked for acceptable packing in the unit cell using the graphics package SETOR (26) . Multiple runs of AMoRe were performed with various modified versions of the model to optimize the quality of the solution. Details of the best solution are shown in Table  I .
Refinement-Initial electron density maps calculated from the molecular replacement solution were of marginal quality and insufficient to permit significant rebuilding of the structure. To improve these maps, density modification procedures were performed with the program DM (27) using solvent flattening, histogram matching, and 2-fold averaging to refine and extend the phases to 2.0-Å resolution. Refinement was carried out using the maximum-likelihood refinement program REFMAC (28) . Five percent of the data were randomly set aside SCHEME 1. AKR7A1 catalyzes the reduction of a wide range of aldehydes and diketones including aflatoxin B 1 dialdehyde. It also has particularly high affinity for SSA and 2-CBA. AFB 1 , aflatoxin B 1 . a Redundacy of data, defined as the ratio of the number of measured and the number of unique reflections.
is the intensity value of the ith measurement of h, and ͗I(h)͘ is the corresponding mean value of h for all i measurements of h; is the summation over all measurements.
c Protein Data Bank code.
as test data for calculation of R free (29). One round of unrestrained refinement using data from 8.0 -1.9 Å with no bulk solvent correction was crucial to the successful refinement of the model as this reduced R work to 49% and R free to 53% and increased the correlation coefficient from 42 to 60%. Cycles of tightly restrained refinement using noncrystallographic symmetry averaging further reduced R work to 48% and R free to 51%. Sixty cycles of the program ARP/WARP (30), adding 40 and removing 20 dummy atoms per cycle and using all data to 1.38-Å resolution reduced R work to 24% and R free to 28%. The output electron density map was then used as input for automated structure building within WARP using the option warpNtrace. After 12 cycles 507 residues in 12 chains were built, which were assembled into A and B chains of AKR7A1, which were 85 and 75% complete (residues 200 -250 were notably absent in both models). Manual correction of the structure and model building and addition of solvent were performed using modules within the program QUANTA (Molecular Simulations Inc.). Five iterations of refinement and manual rebuilding with the addition of molecules of NADP ϩ , citrate, and glycerol and with the application of individual anisotropic temperature factors in the final stages of refinement resulted in a model with the final R work of 15.7% and R free of 17.8%.
RESULTS AND DISCUSSION
Quality of the Model-The data reduction and refinement statistics for the model are summarized in Table I . The structure contains two protein subunits in the asymmetric unit, one is the apoenzyme and the other is the ternary complex (enzyme⅐NADP ϩ ⅐inhibitor), the inhibitor being the tricarboxylic acid citrate. In addition, there are 12 molecules of glycerol and 511 solvent molecules included in the final model. The quality of the refined structure was assessed using PRO-CHECK (31) . The Ramachandran plot showed that all residues are in allowed regions with 91.8% in the most favored regions. The main chain and side chain parameters are within values expected for a 1.4-Å structure, and the overall co-ordinate error is 0.06 Å as estimated by the method of Cruickshank (32 One notable deviation from ideal values is residue Tyr-107 that has a 28°deviation from a planar peptide bond ( angle) and 0.062 r.m.s. distance from planarity in side chain (in both A and B molecules). From inspection of the structure it is evident that this residue adopts a strained conformation due to packing constraints.
Overall Structure-AKR7A1 folds into an ␣/␤-barrel with eight parallel ␤-strands and eight ␣-helices (Fig. 1a) . This class of fold was first identified in triosephosphate isomerase (33) and has been shown to be common to many classes of enzymes including the aldo-keto reductase superfamily. The regular ␣/␤-barrel is interrupted by two additional helices, named H1 and H2 by convention (34) , which are located between ␤7 and ␣7 and between ␣8 and the C terminus, respectively. The base of the ␤-barrel is normally covered by two short ␤-strands formed by the N terminus, but in AKR7A1 these are absent. Instead the bulky R groups of Tyr-191, Arg-189 (which forms a salt bridge with Glu-135), and residues from a loop (residues 270 -275) effectively close off the barrel. The first loop between ␤1 and ␣1 is similar to AKR6A2 but differs significantly from that found in other AKR structures. Helix ␣2 is much shorter than usual with a triple Leu-Gly repeat ending the helix and forming an extended loop structure with the leucines buried in the hydrophobic core. Residues 76 -82 form a loop structure between ␤3 and ␣3 that is present in AKR6A2 but absent in all other AKR structures. In AKR7A1 residues Met-77 and Phe-78 of this loop occupy positions similar to residues Trp-81 and Pro-123 from Loop A in AKR1B1, a 23-amino acid loop that is absent in AKR7A1 and AKR6A2. Residues between ␤7 and helix H1 form Loop B, which is important in cofactor binding. Loop B of AKR7A1, which forms a large lid over the active site, is the longest such loop (35 residues) of any known AKRs compared with 12 residues for AKR1B1. Arg-204, Tyr-204, Pro-215, Ser-217, and Arg-218 from this loop are involved in cofactor binding and occupy the same positions as residues from the AKR6A2 structure. However, in AKR7A1 Loop B extends some 5-6 Å further over the active site, which is almost completely closed off by Phe-224. There are large differences in the position of the secondary structure of the sequence-variable C-terminal portion of AKRs, which has been shown to define substrate specificity (34 -36) . Helices H1 and H2 in most AKRs are 8 -10 residues long but in both AKR6A2 and AKR7A1 are between 12 and 19 residues long. This has the effect of reducing the length of the C-terminal loop in these two structures to 5 residues in contrast to the 23 residues for AKR1B1. In AKR6A2, the C-terminal loop packs outside helix ␣6 far from the active site. However, in AKR7A1 this loop passes over helices ␣5 and ␣6 toward the active site where the terminal carboxylate is anchored in place by hydrogen bonding to the imidazole of His-113. AKR7A1 is therefore similar to other enzymatically active AKRs where the C-terminal residues play a role in the active site.
Dimerization-Of the AKRs that have been characterized to date, almost all have been monomeric, and this has been interpreted as a feature of this superfamily of proteins. A notable exception is AKR6A2 that forms a tetramer thereby matching the 4-fold symmetry of the membrane-bound portion of the channel. AKR7A4 was the first member of the aldo-keto reductase superfamily to be shown to have a dimeric structure (17) . Dynamic light scattering and the crystal structure presented here show that AKR7A1 is also a dimer suggesting that this is a general feature of AKR7 enzymes. The dimer interface buries ϳ2000 Å 2 of solvent accessible surface area, 963 Å 2 contributed by the A chain and 995Å 2 contributed by the B chain with residues Trp-144, Lys-155, Glu-178, and His-320 contributing FIG. 2 . a, the electron density for NADP ϩ calculated from an omit map (the structure refined in the absence of cofactor and contoured at 3.5 and 6.0 difference density) shown against the final refined structure illustrates the quality of the overall structure. b, a schematic representation of the interactions between the cofactor NADP ϩ and enzyme. In addition to hydrogen bonding and electrostatic interactions, the side chain of Phe-193 and the side chain of Gln-290 are involved in stacking against the nicotinamide and guanine rings of NADP ϩ , respectively.
to almost 50% of the buried surface area. The two monomers are related by almost perfect rotational 2-fold symmetry (Fig.  1b) . The interface is rather slender (20 ϫ 35 Å) involving almost exclusively helices ␣5 and ␣6 with eight hydrogen bonds and one salt bridge (between Lys-155 and Glu-118) per subunit. The dimer interface is distinct from the tetramer interface found in the AKR6A2 structure, which involves helices ␣3 and ␣4 and the N-terminal strands ␤1 and ␤2. More generally, several classes of TIM (triosephosphate isomerase) ␣/␤-barrel proteins present in the SCOP data base (37) form dimers, but surprisingly none seem to possess dimerization interfaces that are coincident with AKR7A1. NADP ϩ Binding-The NADP ϩ cofactor binds in an extended conformation in a deep cleft as observed in other aldo-keto reductase enzymes (34) . The cofactor makes numerous contacts with protein with the nicotinamide ring being bound in the core of the ␣/␤-barrel, the pyrophosphate group between the Cterminal edges of ␤-strands ␤7 and ␤8, and the adenine mono- phosphate moiety between helices ␣7, ␣8, and Loop B. The complex between NADP ϩ and AKR7A1 is stabilized by a number of hydrogen bonds, salt bridges, and water-mediated interactions in a similar manner to other AKRs (Fig. 2) . NADP ϩ in complex with AKR7A1 is almost completely buried with only 5% (45 Å 2 ) of the total surface area being solvent-accessible (using a 1.4-Å radius probe). The solvent-accessible fraction of NADP ϩ includes a small portion (10 Å 2 ) of the nicotinamide ring accessible in the active site and part of the adenine ring and single phosphate at the other extremity of the cofactor. The 2Ј-monophosphate of the adenine moiety forms a large number of direct and water-mediated hydrogen bonds to the protein. Although AKR7A1 can use either NADPH or NADH as a cofactor, the large number of interactions with the 2Ј-phosphate group, including charge interactions with Arg-18 and Arg-204, are clearly important for the recognition of NADPH and account for the 180-fold lower K m value for NADPH compared with NADH (16) .
Comparison of Apo and Ternary Complexes-The dimer of AKR7A1 within the crystal contains one polypeptide with NADP ϩ and citrate bound, while the other polypeptide is empty suggesting the possibility of negative cooperativity between the two subunits. In solution the protein was calculated to have one NADPH per polypeptide chain. Although not ruling out communication between active sites, it suggests that the difference between the subunits is due in part to the stabilization of two different conformations by crystal packing.
The presence of both apo and ternary complex within this high resolution crystal structure is, however, fortuitous as it permits a direct comparison of these two enzyme forms. Examination of the differences between the two subunits reveals there is a large hinged movement of the enzyme that in addition to movements of Loop B and helices H1 and H2 also involves those parts of the ␣/␤-barrel most intimately involved in cofactor binding. This conformational change does not occur simply at a domain boundary but involves three regions of the enzyme moving in concert. There are therefore a number of residues that act as hinges (Fig. 3) . The region from Gly-166 to Glu-178, which represents the ␤-turn and short 3 10 helix between ␤6 and ␣6, is buried between helices ␣7, H1, and H2. A significant source of the hinged movement is located at Tyr-191 in the middle of strand ␤7. This movement of ϳ0.8 Å permits Phe-193 to stack against the nicotinamide ring of the cofactor, positioning it correctly for 4-pro-R hydride transfer. On strand ␤8 there is a small (1-Å) movement around residues 284 -286, which move closer to the pyrophosphate of NADP ϩ in part due to the hydrogen bonding of Ser-286. Further conformational changes are evident at the beginning of Loop B. The side chain of Asn-194 in the apoenzyme forms a hydrogen bond with the amide nitrogen of Gly-198, while in the ternary complex it swings around 90°to hydrogen bond with the pyrophosphate portion of NADP ϩ . This conformational change allows the amide nitrogens of to form hydrogen bonds with the pyrophosphate of the cofactor. The R group of Asn-194, in addition to cofactor binding, also forms hydrogen bonds with Tyr-228, Arg-231, and Tyr-232 closing Loop B down over the cofactor and the active site of the enzyme. Loop B is also involved in important charged interactions with the cofactor. The side chain of Arg-204 moves over 6 Å from its position in the apoenzyme to coordinate with both the 2Ј-phosphate group and the AN3 of the adenine ring of NADP ϩ . Arg-218, which is not seen in the apoenzyme, forms a main chain hydrogen bond with the 2Ј-phosphate group and a salt bridge to the cofactor pyrophosphate in the ternary complex.
Active Site-Compared with most other AKRs (34), the structure of AKR7A1 reveals spatial conservation of residues involved in the active site, namely Asp-40, Lys-73, Tyr-45, and His-109. Tyr-45 is considered the side chain likely to act as the proton donor during catalysis. The active sites of most AKRs form a cleft consisting of three elements: an oxyanion-binding site (Tyr-45, His-109, and the C-4N of the nicotinamide ring); certain residues from the three loops A, B, and C; and a series of amino acids that line the active site (Fig. 4) . The most notable feature of the active site pocket of AKR7A1 is the presence of strong positive charge, which is the result of three arginines residues, Arg-17, Arg-231, and the extreme C-terminal Arg-327, that line the active site. The active site pocket has dimensions of 11 ϫ 11 Å and a depth of about 7Å (measured from a molecular surface using the program GRASP (38) ). This is significantly different from the AKR1B1 active site pocket, which is uncharged, has dimensions of 7 ϫ 12 Å, and is much deeper (ϳ14 Å). In addition, rather than there being an aromatic residue in the first loop (A) that sits between the nicotinamide ring and the pyrophosphate of the cofactor and forming a face of the active site, there is in AKR7A1 a methionine (Met-13). This first loop is much shorter than in other AKRs, and as a result, the C␣ of this methionine is some 2 Å away from the equivalent C␣ of Trp-20 in AKR1B1. This shift would be equivalent to mutating this tryptophan to an alanine or valine residue. The net result is to provide AKR7A1 with significantly more space in this region of the active site. In members of the AKR1 family, a significant part of the active site is formed by hydrophobic residues from Loop A and Loop C (Fig.  4) . As both these loops are significantly shorter in AKR7A1, the depth of the active site pocket is consequently considerably reduced. Hydrophobic residues Met-77 and Phe-78 are contributed by a short loop between strand ␤3 and ␣3, and these for 5C. This shows that there is more significant homology between AKR7A1 and AKR6A2 than other AKRs. The ␤-strands are colored green, ␣-helices are purple, Loop A is orange, Loop B is yellow, Loop C is cyan, and a short loop between strand ␤3 and ␣3 is colored red. The surface of each monomer was calculated using GRASP (38) , and the diagram was composed using DINO.
together with Val-44 and Phe-110 make up a hydrophobic surface above the active site residues Tyr-45 and His-109. The C-terminal Arg-327 is the only residue of Loop C to contribute to the active site in stark contrast to the AKR1 enzymes. Many more residues are contributed by the long Loop B structure in AKR7A1: these include Leu-227, Tyr-228, and Arg-231 and in particular Phe-224, which closes over the active site forming an entrance to and exit from the active site pocket. Whereas in AKR1B1, Trp-20 and Trp-219 together with Cys-298 form a predominantly nonpolar surface to the active site, in AKR7A1 this same region is hydrophilic and charged. In particular the guanidinium groups of Arg-231 and Arg-327 are 3.5 Å apart and perpendicular to each other forming a second potential anion-binding site. The extensive differences in the active site pocket between AKR7A1 and AKR1B1 are reflected in the mode of binding of the inhibitor citrate. In AKR1B1, citrate is bound in the active site solely by two hydrogen bonds to Tyr-48 and His-110 and van der Waals contacts to Val-47, Trp-111, and the cofactor NADP ϩ (Fig. 5) . In AKR7A1, in addition to two hydrogen bonds formed by the catalytic residues (Tyr-45 and His-109) to citrate, hydrogen bonds also form to the second carboxylate of citrate and to the hydroxyl moiety via Tyr-228, Arg-231, and Arg-327. In so doing, one of the citrate carboxyl groups is buried within the active site in the region formed by Loop B, while the hydroxyl group of citrate forms hydrogen bonds with the carbonyl of NADP ϩ and guanidinium group of Arg-327.
Substrate Binding and Specificity-AKR7A1 has been shown in vitro to reduce irreversibly a number of aromatic and aliphatic aldehydes and dicarbonyl-containing compounds (16) . Comparison of the substrate specificity of human AKRs (39) has shown that the related human enzyme AKR7A2, while sharing some overlapping substrate specificity with several other AKR1 family enzymes, is distinct in its ability to catalyze the reduction of 2-CBA. In addition, AKR7 family members appear to be unique in their ability to reduce aflatoxin dialdehyde to its dialcohol form (16) . The structure of the dead-end complex of AKR7A1 with NADP ϩ and citrate provides an ex- planation of the unique enzyme specificity of AKR7A1. One of the AKR7A1 substrates, 2-CBA, has two carbons separating the aldehyde and carboxylic acid moieties (Scheme 1); a similar separation occurs between two of the carboxylate groups in citrate. We predict that the aldehyde of 2-CBA will bind in the anion-binding site common to AKRs (40) formed by the catalytic histidine and tyrosine in a position occupied by a carboxylate of citrate in the structure we have determined. However, due to the steric restrictions imposed by the benzene ring, the carboxylate of 2-CBA would also be predicted to be oriented downward into the active site cavity. In AKR7A1 this could be achieved by the carboxylate adopting a conformation similar to that of the second carboxylate of citrate (Fig. 5a ) that binds Tyr-228, Arg-231, and Arg-327. In this orientation the benzene ring in 2-CBA would pack favorably against hydrophobic residues such as Phe-110, Phe-224, and Leu-227. In AKR1 enzymes such as AKR1B1, there would be no equivalent way to bind the carboxylate (Fig. 5b) , providing an explanation as to why 2-CBA is not a good substrate for these enzymes.
The binding of citrate in the active site provides a good model for the binding of aflatoxin B 1 dialdehyde, the substrate originally identified for AKR7A1. This compound has two carbons separating the aldehyde groups, the first carbon with a hydroxyl moiety and the second carbon with the substituted coumarin moiety of aflatoxin (Scheme 1). The two aldehydes and the hydroxyl would most probably bind in the positions occupied by the carboxylates and hydroxyl of citrate in the model, the fused rings of aflatoxin B 1 being external to the cavity. The reduced depth of the active site in AKR7A1 compared with AKR1 enzymes (Fig. 4) may explain why aflatoxin B 1 dialdehyde is a better substrate for the former enzyme: Loop A and the C terminus of AKR1 enzymes would be predicted to clash sterically with the fused rings of aflatoxin.
SSA is a metabolite of the major inhibitory neurotransmitter ␥-aminobutyric acid and has been identified as an in vivo substrate for human AKR7A2, recently characterized as a major SSA reductase in human brain (20) . This enzyme can convert SSA to ␥-hydroxybutyrate, a compound that has a number of important physiological roles. Changes in the concentration of ␥-hydroxybutyrate have been shown to modulate dopamine synthesis and release (41) , and ␥-hydroxybutyrate has been proposed to protect cells during periods of excessive metabolic demand (42) . The amino acid sequence of human AKR7A2 is more similar in sequence to rat AKR7A4 (43) than to rat AKR7A1 reported here and has a significantly lower K m for SSA than does AKR7A1 (17) . Comparison of the sequences in light of the crystal structure of AKR7A1 reveals a significant number of differences between the two enzymes that would be predicted to modify the substrate specificity. In particular Val-44 corresponds to Met, Ala-75 to Asn, Met-77 to Trp, Phe-78 to Asp, and Phe-110 to Thr/Ala, which are all clustered around the active site tyrosine (Tyr-45) and histidine (His-109). In the AKR1 family of enzymes, the amino acid residues immediately preceding the catalytic tyrosine and immediately following the catalytic histidine are thought to contribute to distinguishing between steroid and sugar substrates (34) . In human aldehyde reductase, an arginine, Arg-311, has been shown to contribute to the specificity of this enzyme for substrates such as SSA and is thought to interact with the carboxylic acid of inhibitors such as citrate (36) . In AKR7 enzymes there are two arginines, Arg-231 and Arg-327, that could bind the carboxylate of SSA. It would be convenient to suggest that the mode of binding of SSA is the same in both AKR7A1 and AKR7A2, being essentially similar to that described for 2-CBA based on the binding of citrate. However, this does not explain the 10-fold higher affinity for SSA shown by AKR7A2 compared with AKR7A1 or the greater than 100-fold lower affinity of AKR7A1 for SSA compared with 2-CBA. It is clear from their tissue distribution and substrate specificities (18) that the rat AKR7A1 and the human AKR7A2 enzymes have different functions, and it is likely that some of the differences in substrate specificity could be accounted for by these predicted changes to the structure within their active sites.
